Delivery Order SPE2DR25D1201-SPE2DR26FAKPM
- Not listed
- The Defense Logistics Agency awarded a $3,081.23 delivery order to AmerisourceBergen Drug Corp on January 16, 2026, for the supply of Epinephrine 0.3 mg auto-injector two-packs. This firm fixed-price contract, with a completion date of January 20, 2026, was competitively awarded without set-aside restrictions and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's parent company Cencora, Inc.'s...
- The Defense Logistics Agency awarded a $1,023.31 delivery order to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of Epinephrine 0.15 mg auto-injector 2-packs. This competitively awarded, firm fixed-price delivery order is scheduled for completion by January 13, 2026, with performance at the contractor's Conshohocken, Pennsylvania facility. The contract represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a $8,271.36 delivery order to AmerisourceBergen Drug Corp for epinephrine 0.3 mg auto-injector two-packs on January 9, 2026, with completion scheduled for January 12, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor providing critical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,394.14 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector 2-packs. The contract was awarded on January 2, 2026, with an ultimate completion date of January 5, 2026, and utilizes firm fixed pricing with no set-aside designation. The award represents a competitive procurement action supporting federal medical supply requirements, with performance based in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $5,079.08 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector (2-packs) on January 7, 2026, with an ultimate completion date of January 8, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major...
- The Defense Logistics Agency (DLA) awarded a $4,747.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of epinephrine 0.3 mg auto-injector two-packs. The award, issued on January 9, 2026, with an ultimate completion date of January 12, 2026, represents a non-set-aside competitive procurement from the company's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving federal medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,438.96 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector two-packs. This firm fixed-price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by December 11, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This delivery order...
- The Defense Logistics Agency awarded a $5,625.99 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of epinephrine 0.3 mg auto-injector kits (2-packs). This competitive award, which carries an ultimate completion date of January 13, 2026, represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026. The delivery will be fulfilled from the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,766.06 to AmerisourceBergen Drug Corp for the supply of epinephrine 0.3 mg auto-injector two-packs, with an ultimate completion date of September 17, 2025. This competitively awarded, firm fixed-price delivery order was issued on September 16, 2025, with performance to be fulfilled at the contractor's Conshohocken, Pennsylvania facility. The contract carries no set-aside designation, reflecting open competition among...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,797.24 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector (2-pack) on November 17, 2025, with completion scheduled for November 18, 2025. This non-set-aside, competitively awarded contract employs firm fixed-price pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through...
- SPE2DR25D1201Indefinite Delivery Contract
- SPE2DR25D1201-SPE2DR26FAKPMDelivery Order
The Defense Logistics Agency (DLA) awarded a $11,116.51 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 22, 2026, for the supply of Epinephrine 0.3 mg auto-injector two-packs. The contract, which is a non-set-aside competitive award, will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of January 23, 2026. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor that supplies critical medical products to federal healthcare systems. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), which serves as a comprehensive global pharmaceutical support vehicle. The IDC enables the company to supply a broad range of pharmaceutical products and medical supplies—including specialty medications, vaccines, and medical devices—to support military healthcare programs worldwide. The epinephrine auto-injectors represent essential emergency medical supplies critical to military medical readiness and healthcare operations across the Defense Health Agency and other federal medical facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.1k | 1/21/26 |